0001104659-23-090452.txt : 20230811
0001104659-23-090452.hdr.sgml : 20230811
20230811160057
ACCESSION NUMBER: 0001104659-23-090452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glass Geoffrey Michael
CENTRAL INDEX KEY: 0001517718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 231163865
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BLVD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
tm2323514-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-10
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001517718
Glass Geoffrey Michael
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
1
0
0
0
0
ADSs
2023-08-10
4
P
0
14000
13.40
A
59000
I
By Trust
ADSs
65700
I
By Trust
The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust.
These ADSs are held by Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
/s/ Jerad G. Seurer, Attorney-in-Fact
2023-08-11